Helena Harlin

3.0k total citations · 1 hit paper
25 papers, 2.4k citations indexed

About

Helena Harlin is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Helena Harlin has authored 25 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 13 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Helena Harlin's work include Immunotherapy and Immune Responses (10 papers), T-cell and B-cell Immunology (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Helena Harlin is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), T-cell and B-cell Immunology (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Helena Harlin collaborates with scholars based in United States, Sweden and China. Helena Harlin's co-authors include Yuru Meng, Thomas F. Gajewski, Amy Peterson, Mark D. McKee, Yuanyuan Zha, Maria Tretiakova, Craig L. Slingluff, Craig B. Thompson, Colin S. Duckett and Tullia Lindsten and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Helena Harlin

25 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment

2009 872 citations Helena Harlin, Yuru Meng et al. Cancer Research profile →

Peers

Helena Harlin

IMMUN

ONCOL

GENET

Armelle Prévost‐Blondel France

Beom K. Choi South Korea

Adrienne Luoma United States

Isabel Poschke Germany

Pauline Andreu France

Rajasekharan Somasundaram United States

Lucia De Monte Italy

Flavian D. Brown United States

Elisa Peranzoni France

Lynne Collins United States

Armelle Prévost‐Blondel France

Helena Harlin

1.8k ×1.1

IMMUN

1.4k ×1.0

ONCOL

672 ×0.9

253 ×1.4

141 ×1.0

GENET

Citations per year, relative to Helena Harlin Helena Harlin (= 1×) peers Armelle Prévost‐Blondel

Countries citing papers authored by Helena Harlin

Since Specialization

Citations

This map shows the geographic impact of Helena Harlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Harlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Harlin more than expected).

Fields of papers citing papers by Helena Harlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helena Harlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Harlin. The network helps show where Helena Harlin may publish in the future.

Co-authorship network of co-authors of Helena Harlin

This figure shows the co-authorship network connecting the top 25 collaborators of Helena Harlin. A scholar is included among the top collaborators of Helena Harlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Harlin. Helena Harlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harlin, Helena, Yuru Meng, Amy Peterson, et al.. (2009). Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment. Cancer Research. 69(7). 3077–3085. 872 indexed citations breakdown →

Reschner, Anca, Helena Harlin, Brett A. Laven, et al.. (2009). Expression of immunomodulating genes in prostate cancer and benign prostatic tissue.. PubMed. 31(2). 74–82. 4 indexed citations

Johansson, C. Christian, Suzanne Egyházi, Giuseppe Masucci, et al.. (2008). Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma. Cancer Immunology Immunotherapy. 58(7). 1085–1094. 41 indexed citations

Peterson, Amy, et al.. (2008). The HLA‐A2‐restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer. The Prostate. 69(2). 142–148. 9 indexed citations

Harlin, Helena & Thomas F. Gajewski. (2008). Diagnosis and Treatment of Mycoplasma‐Contaminated Cell Cultures. Current Protocols in Cytometry. 43(1). 7 indexed citations

Harlin, Helena, Mikael Hanson, C. Christian Johansson, et al.. (2007). The CD16−CD56bright NK Cell Subset Is Resistant to Reactive Oxygen Species Produced by Activated Granulocytes and Has Higher Antioxidative Capacity Than the CD16+CD56dim Subset. The Journal of Immunology. 179(7). 4513–4519. 65 indexed citations

Molinero, Luciana, Ping Zhou, Helena Harlin, et al.. (2007). Epidermal Langerhans Cells Promote Skin Allograft Rejection in Mice With NF-κB-impaired T Cells. American Journal of Transplantation. 8(1). 21–31. 19 indexed citations

Gajewski, Thomas F., Meng Yu, & Helena Harlin. (2007). Chemokines expressed in melanoma metastases associated with T cell infiltration. Journal of Clinical Oncology. 25(18_suppl). 8501–8501. 10 indexed citations

Harlin, Helena, et al.. (2006). Tumor progression despite massive influx of activated CD8+ T cells in a patient with malignant melanoma ascites. Cancer Immunology Immunotherapy. 55(10). 1185–1197. 111 indexed citations

10.

Gajewski, Thomas F., Yuru Meng, & Helena Harlin. (2006). Immune Suppression in the Tumor Microenvironment. Journal of Immunotherapy. 29(3). 233–240. 210 indexed citations

11.

Peterson, Amy, Helena Harlin, Theodore Karrison, et al.. (2006). A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma. Investigational New Drugs. 24(2). 141–149. 17 indexed citations

12.

Gajewski, Thomas F., Yuru Meng, Christian U. Blank, et al.. (2006). Immune resistance orchestrated by the tumor microenvironment. Immunological Reviews. 213(1). 131–145. 358 indexed citations

13.

Meng, Yuru, Helena Harlin, James P. O’Keefe, & Thomas F. Gajewski. (2006). Induction of Cytotoxic Granules in Human Memory CD8+ T Cell Subsets Requires Cell Cycle Progression. The Journal of Immunology. 177(3). 1981–1987. 27 indexed citations

14.

Zimmerman, Todd M., Helena Harlin, Olatoyosi Odenike, et al.. (2004). Dose-Ranging Pharmacodynamic Study of Tipifarnib (R115777) in Patients With Relapsed and Refractory Hematologic Malignancies. Journal of Clinical Oncology. 22(23). 4816–4822. 32 indexed citations

15.

Harlin, Helena, Andrew Artz, Mary B. Mahowald, et al.. (2004). Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8+ IFN-γ-producing T cells. Bone Marrow Transplantation. 33(5). 491–497. 21 indexed citations

16.

Harlin, Helena, Theodore Karrison, James A. Knost, et al.. (2004). A randomized phase II trial of Interleukin-2 in combination with four different doses of bryostatin in patients with renal cell carcinoma. Journal of Clinical Oncology. 22(14_suppl). 4608–4608. 1 indexed citations

17.

Smith, Sonali M., David L. Grinblatt, Thomas F. Gajewski, et al.. (2004). Prospective Study of Immunomodulation with GM-CSF, IL-2, and Rituximab Following Autologous Stem Cell Transplant (SCT) in Patients with Relapsed Lymphomas.. Blood. 104(11). 918–918. 1 indexed citations

18.

Tschoep, Katharina, Thomas C. Manning, Helena Harlin, et al.. (2003). Disparate functions of immature and mature human myeloid dendritic cells: implications for dendritic cell-based vaccines. Journal of Leukocyte Biology. 74(1). 69–80. 18 indexed citations

19.

Harlin, Helena, Kwang Woo Hwang, Oliver Kim, et al.. (2002). CTLA-4 engagement regulates NF-κB activation in vivo. European Journal of Immunology. 32(8). 2095–2095. 24 indexed citations

20.

Harlin, Helena, Stephanie Birkey Reffey, Colin S. Duckett, Tullia Lindsten, & Craig B. Thompson. (2001). Characterization of XIAP-Deficient Mice. Molecular and Cellular Biology. 21(10). 3604–3608. 347 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact